Medical researchers throughout the world study donated human organs and tissues to uncover the pathology of various diseases and develop effective treatments and therapies to help combat and, where possible, cure them.
The International Institute for the Advancement of Medicine (IIAM), is at the forefront of providing non-transplantable, healthy and diseased, human organs and tissues to the medical research community for purposes of combatting and curing disease. Working with every organ procurement organization in the U.S., IIAM receives over 15,000 annual organ referrals for research. We enter into unprecedented research collaborations to source livers and other organs for therapeutic applications and pre-clinical investigations targeting a range of debilitating metabolic disorders. — IIAM’s breadth of services also includes a Neonatal Donor Program that provides neonatal organs and tissues for medical research, education and development. These neonatal donors are babies with fatal fetal diagnoses who will pass from natural causes shortly after birth, typically with 37 weeks of gestation and greater. This program provides an opportunity for families to leave a legacy of their baby, and offers a unique and invaluable service to researchers in need of these precious tissues.
As a non-profit with more than 30 years of experience in the field, IIAM is a known and trusted partner to both organ procurement organizations and research institutions worldwide. We work closely with them to honor donor and donor family intentions to the fullest by anticipating the next frontier of research requiring human tissue. And we lead the way in educating the next generation of researchers so that every donor’s legacy leaves the world a healthier place.